title: Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo.
abstract: Human newborns are susceptible to microbial infection related to incompletely defined aspects of the neonatal immune system. To characterize neonatal innate immunity, we studied production of two early response cytokines in response to Toll-like receptor (TLR)-activating microbial stimuli in vitro: the pro-inflammatory cytokine tumor necrosis factor (TNF)-alpha and IL-6, a multifunctional cytokine with antiinflammatory and Th2-polarizing properties. Neonatal cord blood responses to multiple TLR agonists, including poly dI:dC (TLR3), lipopolysaccharide (LPS) (TLR4), flagellin (TLR5), and CpG DNA (TLR9), are characterized by a higher IL-6/TNF-alpha ratio than in adult peripheral blood. Robust LPS-induced IL-6 production is due to both neonatal cellular (monocyte-) and humoral (serum-) factors. Remarkably, serum collected from newborns during the first week of life demonstrates higher IL-6/TNF-alpha ratios than does cord blood, associated with elevations of the IL-6-inducible acute phase reactants CRP and LPS-binding protein in the first days of life. A high ratio of stimulus-induced IL-6/TNF-alpha production is likely to profoundly modulate both innate and adaptive immune responses in the human newborn.
authors.affiliation: Catholic University of the Sacred Heart, Rome, Italy.
authors.forename: Donatella F
authors.initials: DF
authors.lastname: Angelone
authors.forename: Michael R
authors.initials: MR
authors.lastname: Wessels
authors.forename: Melissa
authors.initials: M
authors.lastname: Coughlin
authors.forename: Eugenie E
authors.initials: EE
authors.lastname: Suter
authors.forename: Piero
authors.initials: P
authors.lastname: Valentini
authors.forename: Leslie A
authors.initials: LA
authors.lastname: Kalish
authors.forename: Ofer
authors.initials: O
authors.lastname: Levy
mesh_terms: D000328:Adult; D005408:Flagellin / Q000494:pharmacology; D006801:Humans; D007113:Immunity, Innate; D007231:Infant, Newborn / Q000097:blood / Q000276:immunology*; D015850:Interleukin-6 / Q000097:blood*; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology; D011089:Polydeoxyribonucleotides / Q000494:pharmacology; D051193:Toll-Like Receptors / Q000819:agonists; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis*
chemical_list: C408982:CPG-oligonucleotide; D015850:Interleukin-6; D008070:Lipopolysaccharides; D009838:Oligodeoxyribonucleotides; D011089:Polydeoxyribonucleotides; C439524:TNF protein, human; D051193:Toll-Like Receptors; D014409:Tumor Necrosis Factor-alpha; D005408:Flagellin; C031156:poly d(I-C)